Theme 5. Cardiovascular and Respiratory Systems Engineering
Recent Advances on Cuff-Less Blood Pressure Measurement (Part 1)
Ramakrishna Mukkamala, University of Pittsburgh, USA Alberto Avolio, Macquarie University, Sydney, Australia Juergen Fortin, CEO, CNSystems
Jeramiah Wander, Microsoft Research
Roozbeh Jafari, Texas A&M University, USA
Cuff-less blood pressure (BP) monitoring is expected to improve hypertension awareness and control rates and may now be feasible due to recent technological advances in, e.g., wearable sensing. As a result, cuff-less BP monitoring devices are being widely pursued around the world. This topic is of great interest to the attendees of the IEEE EMBC. This Mini-symposia has been popularly attended in the past eight IEEE EMBCs with participants from academia and industry.
Recent Advances on Cuff-Less Blood Pressure Measurement (Part 2)
Josep Sola, Aktiia, Switzerland
Ramakrishna Mukkamala, University of Pittsburgh, USA
Cuffless blood pressure (BP) monitoring is expected to improve hypertension awareness and control rates and may now be feasible due to recent technological advances in, e.g., wearable sensing. As a result, cuffless BP monitoring devices are being widely pursued around the world. This topic is of great interest to the attendees of the IEEE EMBC. We have organized, and filled to capacity, multiple mini-symposia on the topic at each of the past eight IEEE EMBCs with in attendees from academia and industry. Our proposal includes outstanding speakers in the field from both companies and universities who will outline some of the on recent advances on cuffless BP measurement for the Glasgow meeting. This particular mini-symposium represents part two and focuses on PPG waveform analysis.
Waking up to the science and technology of sleep disorders
Henri Korkalainen, University of Eastern Finland Caren Cao, University of Toronto
Thomas Penzel, Charite University Hospital, Berlin, Germany
The prevalence of sleep disorders, primarily in the form of chronic insomnia or sleep apnea, has been reported to be on the order of 30% globally. These disorders have been shown to be associated with increased risk for obesity, diabetes, hypertension, cardiovascular disease, stroke, depression and substance abuse. The associated non-medical costs, including decrements in quality of life and work productivity, are also substantial. While significant progress in the past few decades have been made in sleep laboratories to better understand the scientific bases of sleep disorders, recent developments in technology are providing the ability to glean insights from patient monitoring in the home. Ubiquitous computing power, advances in machine learning, the growing availability of wearable sensors, and the rapidly diminishing costs of developing wireless platforms are contributing in a big way to the movement towards home-centric, personalized solutions for diagnosis and treatment. Internationally recognized experts will review the state-of-the-art developments in sleep bioengineering and present their contributions to specific areas of research within the field, and discuss the issues that remain unresolved.
Also of Interest…
The following sessions may be applicable to the theme Cardiovascular and Respiratory Systems Engineering although they are primarily listed under a different theme.
|Session title||Primary theme|
|In Silico Clinical Trials for Cardiovascular Disease||4|